RU2003106393A - Твердый препарат с высоким всасыванием - Google Patents
Твердый препарат с высоким всасываниемInfo
- Publication number
- RU2003106393A RU2003106393A RU2003106393/15A RU2003106393A RU2003106393A RU 2003106393 A RU2003106393 A RU 2003106393A RU 2003106393/15 A RU2003106393/15 A RU 2003106393/15A RU 2003106393 A RU2003106393 A RU 2003106393A RU 2003106393 A RU2003106393 A RU 2003106393A
- Authority
- RU
- Russia
- Prior art keywords
- solid preparation
- preparation according
- high performance
- performance solid
- hydrates
- Prior art date
Links
- 239000007787 solid Substances 0.000 title claims 6
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 150000001875 compounds Chemical group 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 229960001367 tartaric acid Drugs 0.000 claims 2
- 235000002906 tartaric acid Nutrition 0.000 claims 2
- 239000011975 tartaric acid Substances 0.000 claims 2
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 claims 1
- 230000001264 neutralization Effects 0.000 claims 1
- -1 quinolone compound Chemical class 0.000 claims 1
- 150000007660 quinolones Chemical class 0.000 claims 1
- 229960003177 sitafloxacin Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Claims (5)
1. Твердый препарат, содержащий по меньшей мере одно соединение, выбранное из хинолоновых соединений или их солей, или их гидратов, и винную кислоту.
2. Твердый препарат по п.1, в котором хинолоновое соединение слабо растворимо в воде при значении рН около нейтрального.
3. Твердый препарат по п.2, который содержит по меньшей мере одно соединение, выбранное из ситафлоксацина, представленного следующей формулой:
или его солей, или его гидратов, и винную кислоту.
4. Твердый препарат по одному из п.п.1-3, который находится в виде таблеток или капсул.
5. Твердый препарат по п.4, который находится в виде капсул.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000239233 | 2000-08-08 | ||
| JP2000-239233 | 2000-08-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2003106393A true RU2003106393A (ru) | 2004-09-20 |
| RU2287328C2 RU2287328C2 (ru) | 2006-11-20 |
Family
ID=18730805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2003106393/15A RU2287328C2 (ru) | 2000-08-08 | 2001-08-07 | Твердый препарат с высоким всасыванием |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6861071B2 (ru) |
| EP (1) | EP1308160A4 (ru) |
| JP (1) | JP3573287B2 (ru) |
| KR (1) | KR100878667B1 (ru) |
| CN (1) | CN1214792C (ru) |
| AR (1) | AR030128A1 (ru) |
| AU (1) | AU2001276748A1 (ru) |
| BR (1) | BR0113055A (ru) |
| CA (1) | CA2417764C (ru) |
| MX (1) | MXPA03001206A (ru) |
| NO (1) | NO323835B1 (ru) |
| RU (1) | RU2287328C2 (ru) |
| TW (1) | TWI278316B (ru) |
| WO (1) | WO2002011726A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2610343A1 (en) * | 2005-03-03 | 2006-09-08 | Takeda Pharmaceutical Company Limited | Release-control composition |
| CN113777180B (zh) * | 2020-08-12 | 2023-05-02 | 济川药业集团有限公司 | 一种同时检测西他沙星及其多种异构体杂质的方法 |
| CN113181125B (zh) * | 2021-04-27 | 2022-07-19 | 海南通用三洋药业有限公司 | 一种西他沙星片剂及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968507A (en) * | 1984-06-20 | 1990-11-06 | Merck & Co., Inc. | Controlled porosity osmotic pump |
| IL90062A (en) | 1988-04-27 | 1994-10-07 | Daiichi Seiyaku Co | History of pyridonecarboxylic acid, their preparation and pharmaceutical preparations containing them |
| CA2085871C (en) | 1991-12-27 | 2002-05-07 | Gerald S. Rork | A controlled release drug dispersion delivery device |
| EP0995447A1 (en) * | 1993-09-09 | 2000-04-26 | Takeda Chemical Industries, Ltd. | Formulation comprising antibacterial substance and antiulcer substance |
| DK0688772T3 (da) * | 1994-06-16 | 1999-11-01 | Lg Chemical Ltd | Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling |
| ATE245638T1 (de) * | 1994-08-12 | 2003-08-15 | Toyama Chemical Co Ltd | Neue chinolon- oder naphthyridoncarbonsäurederivate oder deren salze |
| US5763445A (en) * | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US6057323A (en) * | 1996-03-08 | 2000-05-02 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US5847003A (en) * | 1996-06-04 | 1998-12-08 | Avon Products, Inc. | Oxa acids and related compounds for treating skin conditions |
| ATE197900T1 (de) * | 1996-08-15 | 2000-12-15 | Losan Pharma Gmbh | Gut schluckbare orale arzneiform |
| US6071539A (en) * | 1996-09-20 | 2000-06-06 | Ethypharm, Sa | Effervescent granules and methods for their preparation |
| KR20010014105A (ko) * | 1997-06-23 | 2001-02-26 | 가마쿠라 아키오 | 헬리코박터 감염에 기인한 질환의 예방 또는 치료제 |
| AUPO758297A0 (en) * | 1997-06-27 | 1997-07-24 | Rowe, James Baber | Control of acidic gut syndrome |
| JP4299385B2 (ja) * | 1997-07-15 | 2009-07-22 | 富山化学工業株式会社 | パズフロキサシン細粒剤 |
| JP4299384B2 (ja) * | 1997-07-15 | 2009-07-22 | 富山化学工業株式会社 | 溶出遅延防止細粒剤 |
| IN186245B (ru) * | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
| PL346798A1 (en) | 1998-09-14 | 2002-02-25 | Ranbaxy Lab Ltd | Orally administered controlled drug delivery system providing temporal and spatial control |
-
2001
- 2001-08-07 JP JP2002517062A patent/JP3573287B2/ja not_active Expired - Fee Related
- 2001-08-07 AU AU2001276748A patent/AU2001276748A1/en not_active Abandoned
- 2001-08-07 KR KR1020037000207A patent/KR100878667B1/ko not_active IP Right Cessation
- 2001-08-07 AR ARP010103772A patent/AR030128A1/es unknown
- 2001-08-07 RU RU2003106393/15A patent/RU2287328C2/ru not_active IP Right Cessation
- 2001-08-07 WO PCT/JP2001/006776 patent/WO2002011726A1/ja active Application Filing
- 2001-08-07 CN CNB018136737A patent/CN1214792C/zh not_active Expired - Fee Related
- 2001-08-07 MX MXPA03001206A patent/MXPA03001206A/es active IP Right Grant
- 2001-08-07 CA CA002417764A patent/CA2417764C/en not_active Expired - Fee Related
- 2001-08-07 EP EP01954486A patent/EP1308160A4/en not_active Withdrawn
- 2001-08-07 BR BR0113055-2A patent/BR0113055A/pt not_active Application Discontinuation
- 2001-08-07 US US10/344,044 patent/US6861071B2/en not_active Expired - Fee Related
- 2001-08-08 TW TW090119336A patent/TWI278316B/zh not_active IP Right Cessation
-
2003
- 2003-02-07 NO NO20030626A patent/NO323835B1/no not_active IP Right Cessation
- 2003-12-19 US US10/739,015 patent/US20040132756A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2695274C3 (ru) | Новые композиции и способы их стабилизации | |
| RU2005113661A (ru) | Композиция, содержащая натриевую соль правастатина | |
| EP2428519A3 (en) | Process for the preparation of 17-vinyl- triflates as intermediates | |
| RU96111958A (ru) | Фармацевтическая композиция | |
| RU93056600A (ru) | Фенокси- и феноксиалкилпиперидиновые соединения и антивирусная композиция | |
| RU2003106393A (ru) | Твердый препарат с высоким всасыванием | |
| EA200200939A1 (ru) | Способ получения циталопрама | |
| ATE257831T1 (de) | Synthese von wasserlöslischem 9-dihydroplacitaxel derivate aus 9-dihydro-13-acetylbacchatin iii | |
| RU2002124524A (ru) | Производные n-деацетилтиоколхицина и содержащие их фармацевтические композиции | |
| TW200502235A (en) | Novel benzo[1,2,5]thiadiazoles and pharmaceutical use thereof | |
| TR200002803T2 (tr) | MRP1 inhibe etmek için yöntemler. | |
| BRPI0417300A (pt) | métodos para a preparação de compostos de tiazolpirimidina | |
| RU2224742C2 (ru) | Промежуточные соединения для синтеза производных бензимидазола и способ их получения | |
| TR200002804T2 (tr) | MRP1 inhibe etmek için yöntemler | |
| CA2228078A1 (en) | Composition for oral administration containing pyridazinone compounds | |
| RU2006122472A (ru) | Амлодипина гентизат и способ его получения | |
| RU2004102398A (ru) | Производные бензо[g]хинолина для лечения глаукомы и близорукости | |
| DE69920039D1 (de) | Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung | |
| RU2002132890A (ru) | Способ и композиции для ингибирования артериосклероза | |
| IL71068A0 (en) | N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it | |
| CA2380902A1 (en) | Process to make a sustained release formulation | |
| RU2003107054A (ru) | Новые соединения триоксепана | |
| TH79015A (th) | การเตรียมของแข็งในการดูดซึมสูง | |
| CA2385871A1 (en) | Ltb4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition | |
| WO2002061024A3 (en) | Cleansing composition |